Novo Nordisk A/S (LON:0TDD)
London flag London · Delayed Price · Currency is GBP · Price in USD
65.37
-1.61 (-2.40%)
At close: May 8, 2025

Novo Nordisk Revenue

Novo Nordisk had revenue of 78.09B DKK in the quarter ending March 31, 2025, with 19.49% growth. This brings the company's revenue in the last twelve months to 303.14B, up 24.11% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
303.14B DKK
Revenue Growth
+24.11%
P/S Ratio
6.59
Revenue / Employee
3.92M DKK
Employees
77,349
Market Cap
223.95B GBP

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
HSBC Holdings 44.89B
Shell 217.54B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
British American Tobacco p.l.c. 25.87B
Rolls-Royce Holdings 18.91B
Revenue Rankings